Methadone Expansion in Detention Though the Hospital/Clinic Designation
- Sponsor
- Brendan Saloner
- Study ID
- NCT07707934
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Incarcerated Individuals
- Methadone Maintenance
- Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Learning Collaborative — OTHERAll participants will receive individual and group coaching sessions to facilitate implementation of the hospital/clinic designation.
Study Details
The goal of this clinical trial is to improve implementation of hospital/clinic methadone in several carceral systems and study the effects of implementation on patient outcomes. This study has four Aims: * Evaluate an intervention for carceral staff that will receive individual coaching and group didactic sessions focused on improving adoption and implementation of hospital/clinic methadone. Effects of this intervention will be measured via qualitative interviews and baseline, midpoint and final surveys of participants. * Apply a trial emulation approach to electronic health records from three prison systems currently using hospital/clinic methadone to evaluate the effect of implementation on the initiation and retention of medications for opioid use disorder treatment. * Link Medicaid data to electronic health records from one prison system implementing hospital/clinic methadone to examine the effect of implementation on post-release outcomes, including MOUD use and broader healthcare utilization. * Examine the cost effectiveness and budgetary impact of implementing hospital/clinic methadone.
Key Dates
- First listed
- Jul 16, 2026
- Start date
- Sep 30, 2026
- Status verified
- Jul 2026
- Primary completion
- Sep 30, 2028
- Completion
- May 31, 2030
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Other: Learning CollaborativeAll participants will receive individual and group coaching sessions
Primary Outcome Measure
Patients on methadone through h/c [ Time Frame: At baseline, at month 12, and at month 24 ]
Central Contacts
- Brendan Saloner, PhD401-863-2228
Related Studies
- Houston Emergency Opioid Engagement SystemPHASE4 · Enrolling By Invitation · The University of Texas Health Science Center, Houston · Houston, Texas
- Adjunctive Effects of Psilocybin and a Formulation of BuprenorphinePHASE1 · Recruiting · University of Wisconsin, Madison · Madison, Wisconsin
- Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use DisorderPHASE2 · Not Yet Recruiting · Wayne State University · Detroit, Michigan
- Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health CareEnrolling By Invitation · Palo Alto Veterans Institute for Research · Palo Alto, California